Moderna Raises COVID-19 Vaccine Production Forecast to At Least 600 Million Doses

The company is investing and hiring in order to try to reach 1 billion doses

1 min Read
01.5.2021

By Reuters

Image source: Moderna

(Reuters) – Moderna Inc said on Monday it would produce at least 600 million doses of its COVID-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues to roll-out the vaccine.

The company was working to invest and hire in order to deliver up to 1 billion doses this year, the higher end of its production forecast, it said.

Moderna said it has so far supplied about 18 million doses to U.S. government as part of a deal for 200 million doses. It has also signed a deal with the Canadian government for 40 million doses.

Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur.

_____

Source: Reuters

Healthcare

Pharma M&A Shows an Industry Looking to Specialize

Healthcare Is America’s Most Broken Industry. Can AI Fix It?

Revisiting Freeport-McMoRan … and Bayer

The Long List of Pharmaceuticals in Short Supply

Government May Have No Conscience. But Sometimes It Has a Policy.

It’s Easy For Leaders to Play the Blame Game. Don’t.

To say the current situation isn’t pretty now seems an understatement, and it’s likely to remain chaotic for a while. Which is why it’s so important for leaders of all kinds not to fall prey to the very human tendency to go negative, playing the blame game.

This Prestigious Bank Is Down 90% — Is Now the Time to Buy?

Bargain-hunting friends of mine have been asking: “Should I buy First Republic?” After all, First Republic is prestigious. Facebook founder Mark Zuckerberg got a mortgage there. Dozens of customer surveys rate its satisfaction scores higher than super-brands like Apple and Ritz-Carlton.

Everything an Investor Needs to Know About The Petrodollar and, Um, The Petroyuan

The implications of the dollar potentially losing its status as the global reserve are numerous. Obviously, there may be currency risks, and decreased demand for U.S. Treasuries could lead to rising interest rates. I would also expect to see massive commodity price swings.

Anne Chow

4 min Read
03.30.2023

Anne Chow
4 min Read
03.30.2023

Moderna Raises COVID-19 Vaccine Production Forecast to At Least 600 Million Doses

By Reuters

Pharma M&A Shows an Industry Looking to Specialize

Healthcare Is America’s Most Broken Industry. Can AI Fix It?

Revisiting Freeport-McMoRan … and Bayer

The Long List of Pharmaceuticals in Short Supply

Government May Have No Conscience. But Sometimes It Has a Policy.

It’s Easy For Leaders to Play the Blame Game. Don’t.

This Prestigious Bank Is Down 90% — Is Now the Time to Buy?

Everything an Investor Needs to Know About The Petrodollar and, Um, The Petroyuan

Recession Odds Rising (Plus: Jay Powell, Meet Sal Dali)

Qualcomm Looks to The Horizon and Sees AI

Leaders Concerned About Remote Work Should Be Looking at This Metric

It’s Easy For Leaders to Play the Blame Game. Don’t.

Sign up For our Newsletter

SITEMAP

Contact